We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
-16.26%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
-$2.13B
Cap. Flow
+$457M
Cap. Flow %
3.87%
Top 10 Hldgs %
9.66%
Holding
494
New
75
Increased
149
Reduced
153
Closed
37

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$102M
2
AGNC icon
AGNC Investment
AGNC
+$72.1M
3
MAA icon
Mid-America Apartment Communities
MAA
+$67.5M
4
STZ icon
Constellation Brands
STZ
+$66.9M
5
FANG icon
Diamondback Energy
FANG
+$57.3M

Top Sells

Rank Stock Value
1
NTRI
NutriSystem, Inc.
NTRI
+$72.5M
2
TCBI icon
Texas Capital Bancshares
TCBI
+$61.7M
3
EA icon
Electronic Arts
EA
+$48.9M
4
WAL icon
Western Alliance Bancorporation
WAL
+$47.2M
5
ABMD
Abiomed Inc
ABMD
+$46M

Sector Composition

Rank Sector Weight
1 Healthcare 20.05%
2 Technology 17.64%
3 Industrials 14.71%
4 Consumer Discretionary 13.8%
5 Financials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S
201
DELISTED
Sprint Corporation
S
$22.8M 0.19%
3,917,749
-219,225
-5% -$1.35M
RHT
202
DELISTED
Red Hat Inc
RHT
$22.8M 0.19%
129,650
+44,775
+53% +$7.1M
BLUE
203
DELISTED
bluebird bio
BLUE
$22.2M 0.19%
17,293
+2,958
+21% +$4.54M
EVRI
204
DELISTED
Everi Holdings
EVRI
$22M 0.19%
4,272,139
+432,787
+11% +$2.95M
JNJ icon
205
Johnson & Johnson
JNJ
$640B
$21.8M 0.18%
163,377
+12,016
+8% +$1.68M
PANW icon
206
Palo Alto Networks
PANW
$256B
$21.6M 0.18%
688,350
+9,150
+1% +$285K
EHC icon
207
Encompass Health
EHC
$11.3B
$21.5M 0.18%
438,403
– –
NVS icon
208
Novartis
NVS
$302B
$21.2M 0.18%
275,787
-48,614
-15% -$3.78M
KURA icon
209
Kura Oncology
KURA
$793M
$21.1M 0.18%
1,502,217
– –
CNK icon
210
Cinemark Holdings
CNK
$4.07B
$21M 0.18%
586,778
+43,156
+8% +$1.71M
SUPN icon
211
Supernus Pharmaceuticals
SUPN
$2.7B
$20.7M 0.18%
622,460
+233,125
+60% +$10M
PNC icon
212
PNC Financial Services
PNC
$99.1B
$20.6M 0.17%
176,548
+12,985
+8% +$1.66M
ICPT
213
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$20.4M 0.17%
+202,771
New +$21M
HON icon
214
Honeywell
HON
$76.4B
$20.4M 0.17%
163,700
+5,466
+3% +$746K
ROST icon
215
Ross Stores
ROST
$80.8B
$20.2M 0.17%
242,250
+45,175
+23% +$4.09M
PFE icon
216
Pfizer
PFE
$143B
$20.1M 0.17%
486,490
+35,781
+8% +$1.49M
PG icon
217
Procter & Gamble
PG
$340B
$20M 0.17%
217,713
+71,115
+49% +$6.36M
CVX icon
218
Chevron
CVX
$382B
$19.9M 0.17%
183,388
+40,880
+29% +$4.74M
KO icon
219
Coca-Cola
KO
$383B
$19.9M 0.17%
419,755
+30,872
+8% +$1.48M
EG icon
220
Everest Group
EG
$15.6B
$19.7M 0.17%
90,300
-22,450
-20% -$4.89M
MCD icon
221
McDonald's
MCD
$193B
$19.6M 0.17%
110,396
+35,234
+47% +$6.25M
JBLU icon
222
JetBlue
JBLU
$2.16B
$19.4M 0.16%
1,209,375
+320,325
+36% +$5.58M
QDEL icon
223
QuidelOrtho
QDEL
$1.13B
$19.4M 0.16%
397,803
– –
ROK icon
224
Rockwell Automation
ROK
$51.1B
$19.2M 0.16%
127,825
+46,875
+58% +$7.82M
AMZN icon
225
Amazon
AMZN
$2.44T
$19.2M 0.16%
+256,000
New +$21.3M
7 8
9
10 11

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, Carillon Tower Advisers held 494 positions worth $11.8B, down 15% from $13.9B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Carillon Tower Advisers deployed $457M of net new capital in Q4 2018, opening 75 new positions and adding to 149 existing holdings. Its largest new stake was AGNC Investment: 4,047,600 shares worth $71M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Abiomed Inc, an estimated $46M trimmed.

  • Carillon Tower Advisers's largest Q4 2018 buy was AGNC Investment: 4,047,600 shares worth $71M.
  • Carillon Tower Advisers added most to Centene in Q4 2018, an estimated $102M increase.
  • Carillon Tower Advisers's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $46M.
  • Carillon Tower Advisers fully exited NutriSystem, Inc. in Q4 2018, selling an estimated $72.5M.
  • Carillon Tower Advisers's ten largest holdings make up 9.7% of its $11.8B portfolio in Q4 2018.
  • Carillon Tower Advisers opened 75 new positions and closed 37 in Q4 2018.
  • Carillon Tower Advisers's portfolio value fell 15% quarter-over-quarter to $11.8B.

Based on Carillon Tower Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.